Group | AbN | AbP | T1D | T1D/AbN | AbP/AbN |
---|---|---|---|---|---|
All subjects (p = 0.58) | 1.7 (0.6–3.6) (n = 117) | 2.2 (0.5–5.5) (n = 19) | 2.2 (0.9–4.6) (n = 82) | 1.3 | 1.3 |
CTLA-4 genotype | Â | Â | Â | Â | Â |
A/A | 1.9 (0.7–4.1) (n = 12) | 2.5 (n = 1) | 1.9 (0.8–4.9) (n = 19) | 1.0 | 1.2 |
A/G | 1.5 (0.5–4.0) (n = 21) | 1.7 (0.4–4.2) (n = 7) | 1.9 (0.7–3.8) (n = 16) | 1.2 | 1.1 |
G/G | 1.6 (0.7–3.0) (n = 49) | 2.5 (0.9–5.4) (n = 9) | 2.4 (1.1–4.4) (n = 26) | 1.3 | 1.3 |
Male (p = 0.53) | 1.7 (0.9–2.8) (n = 53) | 2.3 (0.9–4.5) (n = 9) | 2.3 (1.3–3.7) (n = 51) | 1.4 | 1.3 |
Female (p = 0.70) | 1.7 (0.9–2.8) (n = 64) | 2.1 (0.8–4.2) (n = 10) | 2.2 (1.2–3.6) (n = 31) | 1.3 | 1.2 |
DQB1*0201 positive | 1.3 (0.6–2.4) (n = 60) | 1.8 (0.6–4.0) (n = 8) | 2.2 (1.1–3.8) (n = 62) | 1.7 | 1.4 |
DQB1*0201 negative | 2.2 (1.2–3.8) (n = 53) | 3.3 (1.4–6.8) (n = 10) | 1.9 (0.8–3.8) (n = 19) | 0.9 | 1.5 |
DQB1*0302 positive | 1.6 (0.8–2.9) (n = 66) | 2.4 (1.0–4.6) (n = 13) | 2.3 (1.2–3.9) (n = 56) | 1.4 | 1.5 |
DQB1*0302 negative | 1.9 (0.9–3.3) (n = 47) | 2.6 (0.9–5.9) (n = 5) | 1.8 (0.7–3.6) (n = 25) | 1.0 | 1.4 |